NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-040-2009-0-FR-07 A Semiconductor For Measuring Biological Interactions FR EP 09828144.7 Issued
NCI E-040-2009-0-EP-03 A Semiconductor For Measuring Biological Interactions EP National Stage 09828144.7 Issued
NCI E-040-2009-0-CH-05 A Semiconductor For Measuring Biological Interactions CH EP 09828144.7 Issued
NCI E-040-2009-0-GB-08 A Semiconductor For Measuring Biological Interactions GB EP 09828144.7 Issued
NIA E-049-2001-0-JP-15 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof JP DIV 2009-262568 Expired
NIDA E-176-2008-0-PCT-02 A Combination Of Growth Factors Which Can Induce Human Embryonic Stem Cells To Differentiate Into Brain Dopaminergic Neurons PCT PCT PCT/US2009/065007 Expired
NCI E-040-2009-0-PCT-02 Electrical Percolation Biological Semiconductors PCT PCT PCT/US2009/064938 Expired
NIAID E-046-2010-0-US-01 Simian Adenoviral Vector-Based HIV Vaccine US 61/262,312 Abandoned
NIA E-146-1993-0-US-52 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US CON 12/618,481 Abandoned
NCI E-102-2009-0-US-01 A Method For Generating A Beaded Protein Microarray US 61/260,876 Abandoned
NICHD E-299-2009-0-US-01 Methods of Diagnosis and Treatement of Cancer Using Metaiodobenzylguanidine US 61/260,991 Abandoned
NCI E-022-2010-0-US-01 Programmed Death Ligand-1 (PD-L1) Immune Modulation Gene Therapy US 61/261,081 Abandoned
NCI E-025-2010-0-US-01 Nitric Oxide-based Cancer Therapeutic Agents For Lung Cancers With Elevated Levels Of Reactive Oxygen Species (ROS) And/or Low Levels Of Antioxidant Defense/DNA Repair
mechanisms. 		US 61/261,175 Abandoned
NCI E-024-2009-0-EP-05 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS EP DIV 13188475.1 Issued
NCI E-024-2009-0-EP-03 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS EP National Stage 09752261.9 Issued
NCI E-024-2009-0-GB-08 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS GB EP 09752261.9 Issued
NCI E-024-2009-0-DE-06 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS DE EP 09752261.9 Issued
NCI E-024-2009-0-FR-07 GENE SIGNATURE FOR PREDICTING PROGNOSIS OF PATIENTS WITH SOLID TUMORS FR EP 09752261.9 Issued
NCI E-024-2009-0-PCT-02 Gene Signature for Prediction Prognosis of Patients with Solid Tumors PCT PCT PCT/US2009/063883 Expired
NICHD E-153-2007-0-JP-06 NITROXIDE RADICAL AS A TREATMENT FOR NEURODEGENERATION JP National Stage 552929/2009 Abandoned
NIAID E-045-2007-1-US-03 Human Parainfluenza Viruses Having Separated P and C Genes US National Stage 12/599,095 Abandoned
CC E-036-2009-0-IN-07 A Feedback System For Integrating Interventional Planning And Navigation IN National Stage 4497/CHENP/2011 Issued
CC E-036-2009-0-JP-06 A Feedback System For Integrating Interventional Planning And Navigation JP National Stage 2011-539118 Issued
CC E-036-2009-0-EP-04 A Feedback System For Integrating Interventional Planning And Navigation EP National Stage 09760315.3 Issued
CC E-036-2009-0-CN-05 A Feedback System For Integrating Interventional Planning And Navigation CN National Stage 200980148382.X Issued
NIAID E-317-2003-0-US-07 Accelerated Vaccination Strategies To Provide Protection Against Viral Infection US CON 12/613,018 8017130 Expired PDF
CC E-036-2009-0-PCT-02 A Feedback System For Integrating Interventional Planning And Navigation PCT PCT PCT/IB2009/054923 Expired
NIAID E-241-2001-0-US-10 Development of a Preventive Vaccine for Filovirus Infection in Primates US DIV 12/612,625 8124592 Expired PDF
NIAID E-241-2001-0-US-09 Development of a Preventive Vaccine for Filovirus Infection in Primates US DIV 12/612,621 8106027 Expired PDF
NIAID E-241-2001-0-US-08 Development of a Preventive Vaccine for Filovirus Infection in Primate US DIV 12/612,579 8106026 Expired PDF
NICHD E-153-2007-0-US-07 Nitroxide Radical As A Treatment For Neurodegeneration US National Stage 12/530,593 Abandoned
NCATS E-267-2008-0-PCT-02 Substituted Triazines And Purine Compounds, Methods Of Inhibiting Cruzain And Rhodesain And Methods Of Treating Chagas Disease And African Trypanosomiasis PCT PCT PCT/US2009/063078 Expired
NCI E-138-2001-0-US-04 Use of Semenogelin in the Diagonosis, Prognosis And Treatment of Cance US DIV 12/609,817 Abandoned
NHLBI E-142-2009-0-US-01 A Novel Strategy To Regulate Cholesterol Biosynthesis With MicroRNAs US 61/280,170 Abandoned
NINDS E-225-2009-0-US-01 COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF
MITOCHONDRIAL DISEASES 		US 61/256,601 Abandoned
NIAID E-305-2009-0-US-01 Antibody To Lutzomyia Longiapalpis Sand Fly Midgut Protein (LuloPer1): A Novel Leishmania Transmission Blocking Vaccine US 61/256,250 Abandoned
CC E-285-2009-0-US-01 Cryopreservation And Storage Of Human Cellular Products Using Low Molecular Weight Pentastarch, Dimethylsulfoxide (DMSO) And Human Serum Albumin In Plasmalyte A Solution. US 61/256,075 Abandoned
NCI E-138-2006-0-US-03 Highly Soluble Pyrimido-Dione-Quinoline Compounds and Their Use In The Treatment of Cancer US National Stage 12/304,980 8877765 Issued PDF
NIDA E-052-2010-0-AU-01 Toll Like Receptor 4 (TLR4) Antagonists Modify The Action Of Alcohol AU ORD 2009905287 Abandoned
NCI E-132-2010-0-AU-01 Methods Of Diagnosing And Prognosing Colonic Polyps AU ORD 2009905277 Abandoned
NIAID E-066-2003-5-US-04 Monoclonal Antibodies That Bind Or Neutralize Dengue Virus US DIV 12/607,035 8337853 Abandoned PDF
NIMH E-262-2009-0-US-01 2-Fluorothiazole derivatives Useful As Imaging Agents; Methods of Synthesis, And Methods of Use US ORD 12/605,467 Abandoned
NEI E-198-2008-0-US-01 Systemic Immunosuppression in the Treatment of Age-Related Macular Degeneration and Diabetic Retinopathy US 61/254,439 Abandoned
NIDDK E-004-2010-0-US-01 Protection From Obesity And Diabetes By Blockade Of TGF-beta/Smad3 Signaling US 61/254,629 Abandoned
NHGRI E-162-2001-0-US-03 Oligonucleotide-Tagged Semiconductor Nanocyrstrals for Microarray And Fluorescence In Situ Hybridizat US DIV 12/604,296 Abandoned
NIAID E-301-2009-0-US-01 RSV Immunogens, Antibodies and Compositions Thereof US 61/253,826 Abandoned
NCI E-303-2009-0-US-01 Methods, Compositions And Kits For MiRNA In Situ Hybridization Detection, Quantification And Identification Of Cancer Biomarkers And Companion Diagnostic Assay For Cancer Therapy US 61/253,617 Abandoned
NICHD E-040-2005-0-US-12 Methods For Preparing Immunogenic Conjugates US DIV 12/582,420 8481048 Abandoned PDF
NCI E-039-2003-0-US-03 COMBINATORIAL THERAPY FOR PROTEIN SIGNALING DISEASES US CON 12/581,019 8168568 Expired PDF
NICHD E-324-2008-0-PCT-02 Geminin Inhibitors as Tumor Treatment PCT PCT PCT/US2009/060949 Abandoned